Tech Center 1600 • Art Units: 1656
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16623799 | CRISPR/CAS-CYTIDINE DEAMINASE BASED COMPOSITIONS, SYSTEMS, AND METHODS FOR TARGETED NUCLEIC ACID EDITING | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 19071092 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Non-Final OA | Halozyme, Inc. |
| 17748678 | ELECTRON CARRIER, ELECTRON CARRIER PRODUCTION METHOD, AND ELECTRON TRANSFER METHOD | Final Rejection | Panasonic Intellectual Property Management Co., Ltd. |
| 18285732 | NOVEL POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES AND USE FOR SAME | Non-Final OA | TOHOKU UNIVERSITY |
| 17781873 | CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME | Non-Final OA | LG CHEM, LTD |
| 19069321 | SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF | Final Rejection | Zhenglong SUN |
| 18044504 | Therapeutic Antibody Formulations | Non-Final OA | Eli Lilly and Company |
| 18927171 | PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION | Non-Final OA | BTL Healthcare Technologies a,s. |
| 17822992 | Methods For The Identification Of UBQLN2-Mediated Amyotrophic Lateral Sclerosis (ALS) | Non-Final OA | The Regents of the University of Colorado, a body corporate |
| 17786557 | CLEANING COMPOSITIONS COMPRISING DISPERSINS IX | Non-Final OA | Henkel AG & Co. KGaA |
| 17786562 | CLEANING COMPOSITIONS COMPRISING DISPERSINS VI | Final Rejection | Henkel AG & Co. KGaA |
| 18185807 | ACETOLACTATE DECARBOXYLASE | Final Rejection | INTERNATIONAL N&H DENMARK APS |
| 17892163 | MUTANT AMINOACYL-TRNA SYNTHETASES | Non-Final OA | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY |
| 18774233 | ALPHA-AMYLASE VARIANTS | Non-Final OA | NOVOZYMES A/S |
| 18246607 | RECOMBINANT YEAST FOR THE PRODUCTION OF OLIGOPEPTIDE | Non-Final OA | LESAFFRE ET COMPAGNIE |
| 18634640 | COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME | Non-Final OA | National University Corporation Kobe University |
| 18582362 | METHODS AND MICROORGANISMS FOR MAKING 2,3-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS | Final Rejection | PRECIGEN, INC. |
| 18249988 | CARRIER PEPTIDE FRAGMENT AND USE THEREOF | Non-Final OA | TOAGOSEI CO., LTD. |
| 18418248 | S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME | Non-Final OA | Integrated DNA Technologies, Inc. |
| 17999356 | DRUG CONTAINING ACTIVE SULFUR COMPOUND AS ITS MAIN COMPONENT | Non-Final OA | Bio-Xcelerator, Inc. |
| 18460178 | USES OF ADENOSINE BASE EDITORS | Final Rejection | Beam Therapeutics Inc. |
| 17697043 | BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDE REBAUDIOSIDE D4 FROM REBAUDIOSIDE E | Non-Final OA | Conagen Inc. |
| 18473622 | Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene | Non-Final OA | Amicus Therapeutics, Inc. |
| 18473573 | Methods Of Treating Fabry Disease In Patients Having A Mutation In The GLA Gene | Non-Final OA | Amicus Therapeutics, Inc. |
| 17912066 | FRAGMENTS OF HLYA AND USES THEREOF | Non-Final OA | NUMAFERM GmbH |
| 18265998 | YEAST EXTRACT CONTAINING TRIPEPTIDE AND PREPARATION METHOD THEREFOR | Non-Final OA | SAMYANG CORPORATION |
| 18051109 | HYPERACTIVE PIGGYBAC TRANSPOSASES | Non-Final OA | Poseida Therapeutics, Inc. |
| 17786997 | A RECOMBINANT FILAMENTOUS FUNGUS FOR PRODUCING ETHANOL AND ITS CONSTRUCTION AND APPLICATION | Non-Final OA | TIANJIN INSTITUTE OF INDUSTRIAL BIOTECHNOLOGY, CHINESE ACADEMY OF SCIENCES |
| 18270879 | METHOD FOR PRODUCING GENETICALLY MODIFIED CELLS | Non-Final OA | Horizon Discovery Limited |
| 17904498 | ARGININE FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Non-Final OA | East China University of Science and Technology |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy